NEJM· Dana V. Rizk Jonathan Barratt Yusuke Suzuki Hong Zhang Muh Geot Wong Adrian Liew Richard Lafayette Vladimír Tesař Hernán Trimarchi Kevin Carroll Ian S.D. Roberts Vivekanand Jha Alejandra Quevedo Seung Hyeok Han Rosnawati Yahya Chee Kay Cheung Raja Ramachandran Michael Walsh Bobby Chacko Manuel Praga Jin-Bor Chen José Suassuna Jing Xia Lokesh Shah and Vlado Perkovicthe VISIONARY Trial Investigators Group*·· 27 天前精选AI 评分75
Sibeprenlimab 治疗 IgA 肾病 III 期试验最终分析结果发表
Sibeprenlimab in IgA Nephropathy — Final Phase 3 Trial Analysis
AI 导读
NEJM 以提前在线形式发表了 Sibeprenlimab 治疗 IgA 肾病的 III 期试验最终分析(VISIONARY 试验),作者为 Dana V. Rizk 等 VISIONARY Trial Investigators Group 成员。目前可获取的内容仅为期刊目录摘要,未披露具体疗效与安全性数据。
来源:NEJM · nejm.org